Blood test breakthrough study seeks to catch ovarian cancer earlier
NCT ID NCT07491081
Summary
This study aims to improve methods for collecting and processing blood samples that could one day help detect ovarian cancer earlier. Researchers will recruit 1,500 postmenopausal women in Australia to donate blood and provide health information. The main goal is to understand how shipping and storage affect tiny particles in blood that might signal cancer, which could make future screening tests more reliable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mater Misericordiae Ltd
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact Email: •••••@•••••
-
The University of Queensland
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.